Century Therapeutics Inc IPSC

$1.32 -0.06 (-4.35%)

Valuation

Market cap
248,788,000
Revenue TTM
$109,160,000
Net income TTM
$-9,580,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-8.78%
Debt to equity
0.00

Trading

Volume
815,500
Avg volume
844,162
Day's range
$1.25 – $1.39
Shares out
181,597,000
Stochastic %K
10%
Beta
1.78
Analysts
Moderate Buy
Price target
$5.12

Price

Company profile

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308,...

Show more

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Industry
Biotechnology
Sector
Healthcare
Phone
267 817 5790
Website
https://www.centurytx.com
Address
25 North 38th Street, 11th Floor, Philadelphia, United States

Latest news

Stocktwits

surrealskillerr Nov 17, 4:48 PM
$IPSC Why the drop ? I mean, everything is down but this one is more down than others. What justified -10% ?
1 replies
cta7978 Nov 13, 2:16 AM
$SANA $IPSC Grok says I am going to be rich if these T1D functional cures work
0 replies
None_ Nov 13, 1:17 AM
$IPSC https://finance.yahoo.com/healthcare/articles/century-therapeutics-reports-third-quarter-120500888.html
0 replies
focafoca99 Nov 12, 12:33 PM
$IPSC released its September 2026 quarter financial results via a press release.
0 replies
diedhddl Nov 9, 3:02 AM
$SANA Delivery route is an underrated variable in the T1D cell therapy race. $IPSC CNTY-813 goes intraportal. That’s the 25-year standard from cadaveric islet transplant, and it works — but it requires interventional radiology or transplant surgery at centers that do islet transplants. There aren’t many of those. Sana’s CEO has cited ~5% hospitalization from clotting or bleeding with the intraportal route as one reason they avoided it. $SANA SC451 goes intramuscular. Harr’s precedent: parathyroid autotransplant into forearm muscle, ~14,000 times a year in the US, works every time. That’s a procedure a general endocrinology clinic can do. Neither matters much for Phase 1 — a handful of expert sites is enough either way. It matters for commercial uptake. $IOVA is the cautionary tale: the data wasn’t the problem, authorized treatment center capacity was. Building centers isn’t a money problem, it’s a time problem. Not investment advice. I’m long $SANA.
4 replies
None_ Oct 27, 10:18 PM
$ARTV $CRSP $FATE $IPSC $NKTX Artiva's first fatal event being attributed to fludarabine is particularly relevant to the autoimmune CAR field. These are patients with autoimmune disease, not cancer. If you can get away from intensive lymphodepletion, that's a major advantage. Fate's fludarabine-free, less-intensive conditioning potentially removes one of the major sources of risk. It makes the conditioning-free FT819 cohort particularly important. https://www.fiercebiotech.com/biotech/artiva-lays-94-staff-after-deaths-and-durability-sink-autoimmune-cell-therapy
0 replies
PJB001 Oct 20, 5:29 PM
$IPSC hmmm not moving
0 replies
PJB001 Oct 20, 5:13 PM
$IPSC hoping for 1.8-1.9 towards the end of the day here
1 replies